Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Andrology

  Free Subscription


Articles published in Curr Opin Urol

Retrieve available abstracts of 70 articles:
HTML format



Single Articles


    July 2021
  1. SINATTI C, Schechter MY, Spinoit AF, Hoebeke P, et al
    Long-term outcome of urethral and genital reconstruction in hypospadias and exstrophy-epispadias complex.
    Curr Opin Urol. 2021 Jul 6. pii: 00042307-900000000-98848.
    PubMed     Abstract available


    June 2021
  2. SPIVAK L, Morozov A, Shpikina A, Enikeev D, et al
    Postoperative medical treatment of lower urinary tract symptoms after benign prostatic hyperplasia surgery. Are we underestimating the problem?
    Curr Opin Urol. 2021 Jun 25. pii: 00042307-900000000-98854.
    PubMed     Abstract available


    May 2021
  3. HEIDENREICH A, Pfister D, Paffenholz P
    Salvage management of patients with relapsing testicular germ cell tumors.
    Curr Opin Urol. 2021;31:206-213.
    PubMed     Abstract available


  4. SAIDIAN A, Ceballos B, Necchi A, Baumgarten AS, et al
    Salvage therapy for localized recurrences of penile cancer.
    Curr Opin Urol. 2021;31:214-219.
    PubMed     Abstract available


    January 2021
  5. CARDOSO A, Lima E
    Urethra-sparing minimally invasive simple prostatectomy: an old technique revisited.
    Curr Opin Urol. 2021;31:18-23.
    PubMed     Abstract available


  6. VISSER WR, Smith-Harrison LI, Krzastek SC
    Surgical procedures for male infertility: an update.
    Curr Opin Urol. 2021;31:43-48.
    PubMed     Abstract available


    November 2020
  7. ENIKEEV D, Traxer O, Taratkin M, Okhunov Z, et al
    A review of thulium-fiber laser in stone lithotripsy and soft tissue surgery.
    Curr Opin Urol. 2020;30:853-860.
    PubMed     Abstract available


    September 2020
  8. QUHAL F, Pradere B, Mori K, Shariat SF, et al
    Volume outcome relationship in penile cancer: a systematic review.
    Curr Opin Urol. 2020;30:696-700.
    PubMed     Abstract available


  9. CALABRO D, Telo S, Ambrosini V
    PET imaging in testicular tumours.
    Curr Opin Urol. 2020;30:665-671.
    PubMed     Abstract available


    May 2020
  10. RAY A, Fernstrum A, Mahran A, Thirumavalavan N, et al
    Testosterone therapy and risk of breast cancer development: a systematic review.
    Curr Opin Urol. 2020;30:340-348.
    PubMed     Abstract available


  11. SOFTNESS KA, Trussler JT, Carrasquillo RJ
    Advanced sperm testing.
    Curr Opin Urol. 2020;30:290-295.
    PubMed     Abstract available


  12. LUNDY SD, Vij SC, Rezk AH, Cohen JA, et al
    The microbiome of the infertile male.
    Curr Opin Urol. 2020;30:355-362.
    PubMed     Abstract available


  13. PHILLIPS D, Chan JYH, Flannigan R
    Evaluating collagenase Clostridium histolyticum administration protocols in the treatment of Peyronie's disease.
    Curr Opin Urol. 2020;30:328-333.
    PubMed     Abstract available


  14. MASTERSON TA, Nassau DE, Ramasamy R
    A clinical algorithm for management of fertility in adolescents with the Klinefelter syndrome.
    Curr Opin Urol. 2020;30:324-327.
    PubMed     Abstract available


  15. LIU JL, Pena V, Fletcher SA, Kohn TP, et al
    Genetic testing in male infertility - reassessing screening thresholds.
    Curr Opin Urol. 2020;30:317-323.
    PubMed     Abstract available


  16. KHODAMORADI K, Parmar M, Khosravizadeh Z, Kuchakulla M, et al
    The role of leptin and obesity on male infertility.
    Curr Opin Urol. 2020;30:334-339.
    PubMed     Abstract available


  17. PARMAR M, Masterson JM, Masterson TA 3rd
    The role of imaging in the diagnosis and management of Peyronie's disease.
    Curr Opin Urol. 2020;30:283-289.
    PubMed     Abstract available


  18. MANN U, Shiff B, Patel P
    Reasons for worldwide decline in male fertility.
    Curr Opin Urol. 2020;30:296-301.
    PubMed     Abstract available


    March 2020
  19. INGRAM CF, Payne KS, Messore M, Scovell JM, et al
    Testosterone therapy and other treatment modalities for female sexual dysfunction.
    Curr Opin Urol. 2020 Mar 19. doi: 10.1097/MOU.0000000000000759.
    PubMed     Abstract available


  20. RESCH I, Abufaraj M, Hubner NA, Shariat SF, et al
    An update on systemic therapy for penile cancer.
    Curr Opin Urol. 2020;30:229-233.
    PubMed     Abstract available


  21. DA COSTA NUNES JF, Pires S, Chade DC
    Human papillomavirus vaccination and prevention of intraepithelial neoplasia and penile cancer: review article.
    Curr Opin Urol. 2020;30:208-212.
    PubMed     Abstract available


  22. KERN SQ, Speir RW, Akgul M, Cary C, et al
    Rare benign and malignant testicular lesions: histopathology and management.
    Curr Opin Urol. 2020;30:235-244.
    PubMed     Abstract available


  23. BANDINI M, Pederzoli F, Necchi A
    Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge.
    Curr Opin Urol. 2020;30:218-222.
    PubMed     Abstract available


  24. BROUWER OR, Chade D
    Editorial: Updates on penile cancer management: where do we stand, and how to move forward?
    Curr Opin Urol. 2020;30:200-201.
    PubMed    


  25. ALNAJJAR HM, Randhawa K, Muneer A
    Localized disease: types of reconstruction/plastic surgery techniques after glans resurfacing/glansectomy/partial/total penectomy.
    Curr Opin Urol. 2020;30:213-217.
    PubMed     Abstract available


  26. DE VRIES HM, Ottenhof SR, van der Heijden MS, Pos FJ, et al
    Management of the penile squamous cell carcinoma patient after node positive radical inguinal lymph node dissection: current evidence and future prospects.
    Curr Opin Urol. 2020;30:223-228.
    PubMed     Abstract available


  27. THOMAS A, Vanthoor J, Vos G, Tsaur I, et al
    Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy.
    Curr Opin Urol. 2020;30:202-207.
    PubMed     Abstract available


  28. NASON GJ, Leao R, Hamilton RJ
    Active surveillance in stage 1 disease: standard of care independent of risk factors?
    Curr Opin Urol. 2020;30:245-250.
    PubMed     Abstract available


    January 2020
  29. HEIDENREICH A, Paffenholz P, Nestler T, Pfister D, et al
    Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors.
    Curr Opin Urol. 2020 Jan 16. doi: 10.1097/MOU.0000000000000736.
    PubMed     Abstract available


  30. NAPPI L, Kollmannsberger C, Nichols C
    The role of micro-RNAs in management of germ cell tumors: future directions.
    Curr Opin Urol. 2020 Jan 16. doi: 10.1097/MOU.0000000000000726.
    PubMed     Abstract available


  31. DANESHMAND S
    Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer.
    Curr Opin Urol. 2020 Jan 9. doi: 10.1097/MOU.0000000000000725.
    PubMed    


  32. ILIJAZI D, Shariat SF, Hassler MR, Lemberger U, et al
    Epigenetic alterations of testicular germ cell tumours.
    Curr Opin Urol. 2020 Jan 3. doi: 10.1097/MOU.0000000000000724.
    PubMed     Abstract available


  33. ENIKEEV D, Shariat SF, Taratkin M, Glybochko P, et al
    The changing role of lasers in urologic surgery.
    Curr Opin Urol. 2020;30:24-29.
    PubMed     Abstract available


    July 2019
  34. CHAHOUD J, Pickering CR, Pettaway CA
    Genetics and penile cancer: recent developments and implications.
    Curr Opin Urol. 2019;29:364-370.
    PubMed     Abstract available


    May 2019
  35. CRAIG KM, Lee RK
    Greenlight laser enucleation of the prostate.
    Curr Opin Urol. 2019;29:306-307.
    PubMed    


  36. SCOFFONE CM, Cracco CM
    Holmium laser enucleation of the prostate.
    Curr Opin Urol. 2019;29:304-305.
    PubMed    


  37. NETSCH C, Gross AJ
    Thulium laser enucleation of the prostate.
    Curr Opin Urol. 2019;29:302-303.
    PubMed    


  38. LIATSIKOS E
    Laser enucleation of the prostate. Introduction.
    Curr Opin Urol. 2019;29:301.
    PubMed    


  39. CHIPOLLINI J, Garcia-Castaneda J, Harb-De la Rosa A, Cheriyan S, et al
    Important surgical concepts and techniques in inguinal lymph node dissection.
    Curr Opin Urol. 2019;29:286-292.
    PubMed     Abstract available


  40. CHU KY, Patel P, Ramasamy R
    Consideration of gender differences in infertility evaluation.
    Curr Opin Urol. 2019;29:267-271.
    PubMed     Abstract available


    April 2019
  41. SINGLA N, Lafin JT, Ghandour RA, Kaffenberger S, et al
    Genetics of testicular germ cell tumors.
    Curr Opin Urol. 2019 Apr 30. doi: 10.1097/MOU.0000000000000642.
    PubMed     Abstract available


  42. POZZI E, Muneer A, Sangster P, Alnajjar HM, et al
    Stem-cell regenerative medicine as applied to the penis.
    Curr Opin Urol. 2019 Apr 16. doi: 10.1097/MOU.0000000000000636.
    PubMed     Abstract available


    March 2019
  43. CRAIG KM, Lee RK
    Point-Counterpoint: Greenlight laser enucleation for management of benign prostatic hyperplasia: a review of current literature.
    Curr Opin Urol. 2019 Mar 27. doi: 10.1097/MOU.0000000000000611.
    PubMed     Abstract available


  44. ALBERSEN M, Spiess PE
    Editorial: penile cancer.
    Curr Opin Urol. 2019;29:143-144.
    PubMed    


  45. RASKIN Y, Vanthoor J, Milenkovic U, Muneer A, et al
    Organ-sparing surgical and nonsurgical modalities in primary penile cancer treatment.
    Curr Opin Urol. 2019;29:156-164.
    PubMed     Abstract available


  46. NABAVIZADEH R, Master V
    Minimally invasive approaches to the inguinal nodes in cN0 patients.
    Curr Opin Urol. 2019;29:165-172.
    PubMed     Abstract available


  47. DE VRIES HM, Brouwer OR, Heijmink S, Horenblas S, et al
    Recent developments in penile cancer imaging.
    Curr Opin Urol. 2019;29:150-155.
    PubMed     Abstract available


  48. DOUGLAWI A, Masterson TA
    Penile cancer epidemiology and risk factors: a contemporary review.
    Curr Opin Urol. 2019;29:145-149.
    PubMed     Abstract available


    December 2018
  49. MITTAKANTI HR, Porter JR
    Robotic retroperitoneal lymph node dissection for testicular cancer: feasibility and latest outcomes.
    Curr Opin Urol. 2018 Dec 24. doi: 10.1097/MOU.0000000000000582.
    PubMed     Abstract available


    October 2018
  50. SHAH A, Nassiri N, Daneshmand S
    Management of extraretroperitoneal masses in germ cell tumor.
    Curr Opin Urol. 2018 Oct 16. doi: 10.1097/MOU.0000000000000563.
    PubMed     Abstract available


    September 2018
  51. SUAREZ-IBARROLA R, Abufaraj M, Shariat SF
    Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
    Curr Opin Urol. 2018;28:485-490.
    PubMed     Abstract available


    July 2018
  52. WOLDU SL, Bagrodia A
    Update on epidemiologic considerations and treatment trends in testicular cancer.
    Curr Opin Urol. 2018 Jul 12. doi: 10.1097/MOU.0000000000000532.
    PubMed     Abstract available


  53. PEDRAZA AM, Stephenson AJ
    Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours.
    Curr Opin Urol. 2018 Jul 3. doi: 10.1097/MOU.0000000000000525.
    PubMed     Abstract available


  54. ALBANY C
    Current medical management of patients with poor-risk metastatic germ-cell tumors.
    Curr Opin Urol. 2018 Jul 3. doi: 10.1097/MOU.0000000000000529.
    PubMed     Abstract available


    March 2018
  55. STROPE SA
    Evidence-based guidelines in lower urinary tract symptoms secondary to benign prostatic hyperplasia and variation in care.
    Curr Opin Urol. 2018 Mar 29. doi: 10.1097/MOU.0000000000000504.
    PubMed     Abstract available


  56. YOUNG S, Golzarian J
    Prostatic artery embolization for benign prostatic hyperplasia: a review.
    Curr Opin Urol. 2018 Mar 13. doi: 10.1097/MOU.0000000000000495.
    PubMed     Abstract available


  57. MORDASINI L, Moschini M, Mattei A, Iselin C, et al
    GreenLight Laser for benign prostatic hyperplasia.
    Curr Opin Urol. 2018 Mar 9. doi: 10.1097/MOU.0000000000000500.
    PubMed     Abstract available


    August 2017
  58. YALAMANCHI S, Dobs A
    Debate position: cognition and mood are not improved in men administered exogenous testosterone therapy.
    Curr Opin Urol. 2017 Aug 24. doi: 10.1097/MOU.0000000000000435.
    PubMed     Abstract available


  59. RIZK PJ, Kohn TP, Pastuszak AW, Khera M, et al
    Testosterone therapy improves erectile function and libido in hypogonadal men.
    Curr Opin Urol. 2017 Aug 14. doi: 10.1097/MOU.0000000000000442.
    PubMed     Abstract available


  60. AKERMAN J, Kovac JR, Lipshultz LI
    Testosterone therapy improves well being and psychological health.
    Curr Opin Urol. 2017 Aug 8. doi: 10.1097/MOU.0000000000000440.
    PubMed     Abstract available


  61. FUGH-BERMAN A, Scialli AR
    Testosterone and sexual function.
    Curr Opin Urol. 2017 Aug 8. doi: 10.1097/MOU.0000000000000438.
    PubMed     Abstract available


    March 2016
  62. CAPOGROSSO P, Montorsi F
    Men's health and quality of life.
    Curr Opin Urol. 2016;26:121-2.
    PubMed    


  63. KHERA M
    Male hormones and men's quality of life.
    Curr Opin Urol. 2016;26:152-7.
    PubMed     Abstract available


  64. VENTIMIGLIA E, Montorsi F, Salonia A
    Comorbidities and male infertility: a worrisome picture.
    Curr Opin Urol. 2016;26:146-51.
    PubMed     Abstract available


  65. SOEBADI MA, Moris L, Castiglione F, Weyne E, et al
    Advances in stem cell research for the treatment of male sexual dysfunctions.
    Curr Opin Urol. 2016;26:129-39.
    PubMed     Abstract available


    January 2016
  66. STONE BV, Chughtai B, Kaplan SA, Te AE, et al
    GreenLight laser for prostates over 100 ml: what is the evidence?
    Curr Opin Urol. 2016;26:28-34.
    PubMed     Abstract available


  67. CORNU JN, Grise P
    Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Curr Opin Urol. 2016;26:17-21.
    PubMed     Abstract available


  68. RADEMAKERS KL, van Koeveringe GA, Oelke M
    Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
    Curr Opin Urol. 2016;26:3-10.
    PubMed     Abstract available


  69. CHUNG A, Woo HH
    Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered?
    Curr Opin Urol. 2016;26:42-8.
    PubMed     Abstract available


  70. RIEKEN M, Bachmann A, Shariat SF
    Long-term follow-up data more than 5 years after surgical management of benign prostate obstruction: who stands the test of time?
    Curr Opin Urol. 2016;26:22-7.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Andrology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: